Displaying 3661 - 3680 of 4770
Resale Price Maintenance Under the Sherman Act and the Federal Trade Commission Act
Statement in the Matter of Rambus
Rambus Inc., In the Matter of
The Commission filed an administrative complaint charging that between 1991 and 1996 Rambus, Inc. joined and participated in the JEDEC Solid State Technology Association (JEDEC), the leading standard-setting industry for computer memory. According to the complaint, while a member of JEDEC, Rambus observed standard-setting work involving technologies which Rambus believed were or could be covered by its patent applications, but failed to disclose this to JEDEC. In 1999 and 2000, after JEDEC had adopted industry-wide standards incorporating the technologies at issue and the industry had become locked in to the use of those technologies, Rambus sought to enforce its patents against companies producing JEDEC-compliant memory, and collected substantial royalties from several producers of DRAM (dynamic random access memory).
The administrative law judge dismissed all charges against Rambus, finding that Rambus’ conduct before the JEDEC standard-setting organization did not amount to deception and did not violate any extrinsic duties, such as a duty of good faith to disclose patents or patent applications. Upon review, the FTC issued an opinion concluding that Rambus unlawfully monopolized markets for four computer memory technologies that have been incorporated into industry standards DRAM chips. The Commission found that, through a course of deceptive conduct, Rambus was able to distort a critical standard-setting process and engage in an anticompetitive “hold up” of the computer memory industry. In a separate opinion on the appropriate remedy, the Commission barred Rambus from making misrepresentations or omissions to standard-setting organizations, and required Rambus to license its SDRAM and DDR SDRAM technology and setting limits to the royalty rates it can collect under the licensing agreements.Tp>
Rambus appealed the Commission’s order to the U.S. Court of Appeals for the District of Columbia Circuit, and in April 2008, the appellate court set aside the Commissions final orders. The Supreme Court denied the Commission's Petition for Writ of Certiorari, and on May 14, 2009 the Commission formally dismissed the complaint.
Competition Senior Deputy Director Ken Glazer to Leave FTC
The Evolving IP Marketplace
FTC Staff Advises Louisiana Legislature That Bill Would Restrict Competition to Provide Dental Care to the State's Underserved Children; At FTC's Request, District Court Halts Illegal Operations of Federal Loan Modification Law Center
The Evolving IP Marketplace
FTC Seeks Public Comment on Revised Proposed Rule Prohibiting Petroleum Market Manipulation
Commission Approves Final Consent Order in Matter of National Association of Music Merchants, Inc.
FTC Staff Advises Maryland Physician-Hospital Organization That it Will Not Recommend Antitrust Challenge to Proposal to Provide Member Physicians Services Through Clinical Integration Program
National Association of Music Merchants, Inc., In the Matter of
The National Association of Music Merchants (NAMM), a trade association with more than 9,000 members nationwide, settled charges that it violated federal law by enabling and encouraging the exchange of competitively sensitive price information among its members. The FTC alleged that NAMM organized meetings at which its members were encouraged to communicate, and did in fact share, information about prices and business strategy. To the detriment of consumers, NAMM’s conduct enhanced the members’ ability to coordinate price increases for musical instruments. In settling the complaint, NAMM agreed to stop engaging in such conduct.
Lubrizol Corporation, The, and The Lockhart Company, In the Matter of
The Commission challenged Lubrizol Corporation’s consummated 2007 acquisition of the oxidate assets of The Lockhart Company which had the effect of substantially lessening competition in the already highly concentrated U.S. market for chemical rust inhibitors. These inhibitors are commonly used to prevent rusting during the manufacture of metal products such as automobiles and other heavy equipment. According to the Commission’s complaint the acquisition removed Lubrizol’s last substantial competitor in the relevant market. In addition, the Commission challenged a non-compete agreement included in the terms of the acquisition which prevented Lockhart from competing in the relevant market for 5 years as anticompetitive because it restrained the ability of new firms to enter the market. The Commission issued a consent order remedying its anticompetitive concerns requiring the divestiture of the oxidate assets in question to Additives International and the elimination of the non-compete agreement.
Public Hearing in Berkeley, California, to Focus on Intellectual Property
FTC Halts Bogus Cancer Cures
FTC Staff Comment Says New York Bill to Regulate Pharmacy Benefit Managers May Increase Pharmaceutical Prices for New York Consumers; Commission Approves Final Consent Order in Matter of Dow Chemical Company and Rohm & Haas Company
FTC Intervenes in BASFs Proposed $5.1 Billion Acquisition of Ciba Holding Inc.
Competition Acting Director David Wales to Leave FTC
FTC Testifies in Support of Bill Banning Pay-for-Delay Settlements Between Brand and Generic Drug Companies
Bristol-Myers Squibb to Pay $2.1 Million Penalty for Failure to Disclose Agreement Involving Substantial Payments to Delay Entry of a Generic Version of the Drug Plavix
Displaying 3661 - 3680 of 4770